Is idiopathic pulmonary fibrosis a cancer-like disease? Transcriptome analysis to fuel the debate: Transcriptome analysis to fuel the debate

C. Arnold Spek; Jan Willem Duitman

doi:10.1183/23120541.00157-2018

Is idiopathic pulmonary fibrosis a cancer-like disease? Transcriptome analysis to fuel the debate: Transcriptome analysis to fuel the debate

C. Arnold Spek^*
, Jan Willem Duitman

^*Corresponding author for this work

Research output: Contribution to journal › Comment/Letter to the editor › Academic

4 Downloads (Pure)

Abstract

Despite promising examples of anticancer drugs as potential treatment modalities for IPF, these transcriptome data argue against the general nature of anticancer drugs as anti-IPF drugs http://ow.ly/HjsV30nbcji.

Original language	English
Article number	00157-2018
Journal	ERJ open research
Volume	5
Issue number	1
DOIs	https://doi.org/10.1183/23120541.00157-2018
Publication status	Published - 1 Feb 2019

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1183/23120541.00157-2018

Is-idiopathic-pulmonary-fibrosis-a-cancer-like-disease-transcriptome-analysis-to-fuel-the-debate.pdfFinal published version, 375 KBLicence: CC BY

Cite this

@article{b1756d59b7f8440290af08e90c708b61,

title = "Is idiopathic pulmonary fibrosis a cancer-like disease? Transcriptome analysis to fuel the debate: Transcriptome analysis to fuel the debate",

abstract = "Despite promising examples of anticancer drugs as potential treatment modalities for IPF, these transcriptome data argue against the general nature of anticancer drugs as anti-IPF drugs http://ow.ly/HjsV30nbcji.",

author = "Spek, \{C. Arnold\} and Duitman, \{Jan Willem\}",

year = "2019",

month = feb,

day = "1",

doi = "10.1183/23120541.00157-2018",

language = "English",

volume = "5",

journal = "ERJ open research",

issn = "2312-0541",

publisher = "European Respiratory Society",

number = "1",

}

TY - JOUR

T1 - Is idiopathic pulmonary fibrosis a cancer-like disease? Transcriptome analysis to fuel the debate

T2 - Transcriptome analysis to fuel the debate

AU - Spek, C. Arnold

AU - Duitman, Jan Willem

PY - 2019/2/1

Y1 - 2019/2/1

N2 - Despite promising examples of anticancer drugs as potential treatment modalities for IPF, these transcriptome data argue against the general nature of anticancer drugs as anti-IPF drugs http://ow.ly/HjsV30nbcji.

AB - Despite promising examples of anticancer drugs as potential treatment modalities for IPF, these transcriptome data argue against the general nature of anticancer drugs as anti-IPF drugs http://ow.ly/HjsV30nbcji.

UR - https://www.scopus.com/pages/publications/85063876641

U2 - 10.1183/23120541.00157-2018

DO - 10.1183/23120541.00157-2018

M3 - Comment/Letter to the editor

AN - SCOPUS:85063876641

SN - 2312-0541

VL - 5

JO - ERJ open research

JF - ERJ open research

IS - 1

M1 - 00157-2018

ER -

Is idiopathic pulmonary fibrosis a cancer-like disease? Transcriptome analysis to fuel the debate: Transcriptome analysis to fuel the debate

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this